Cargando…

Long non-coding RNAs in cutaneous melanoma: clinical perspectives

Metastatic melanoma of the skin has a high mortality despite the recent introduction of targeted therapy and immunotherapy. Long non-coding RNAs (lncRNAs) are defined as transcripts of more than 200 nucleotides in length that lack protein-coding potential. There is growing evidence that lncRNAs play...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulstaert, Eva, Brochez, Lieve, Volders, Pieter-Jan, Vandesompele, Jo, Mestdagh, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522162/
https://www.ncbi.nlm.nih.gov/pubmed/28415644
http://dx.doi.org/10.18632/oncotarget.16478
_version_ 1783252114929090560
author Hulstaert, Eva
Brochez, Lieve
Volders, Pieter-Jan
Vandesompele, Jo
Mestdagh, Pieter
author_facet Hulstaert, Eva
Brochez, Lieve
Volders, Pieter-Jan
Vandesompele, Jo
Mestdagh, Pieter
author_sort Hulstaert, Eva
collection PubMed
description Metastatic melanoma of the skin has a high mortality despite the recent introduction of targeted therapy and immunotherapy. Long non-coding RNAs (lncRNAs) are defined as transcripts of more than 200 nucleotides in length that lack protein-coding potential. There is growing evidence that lncRNAs play an important role in gene regulation, including oncogenesis. We present 13 lncRNA genes involved in the pathogenesis of cutaneous melanoma through a variety of pathways and molecular interactions. Some of these lncRNAs are possible biomarkers or therapeutic targets for malignant melanoma.
format Online
Article
Text
id pubmed-5522162
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-55221622017-08-08 Long non-coding RNAs in cutaneous melanoma: clinical perspectives Hulstaert, Eva Brochez, Lieve Volders, Pieter-Jan Vandesompele, Jo Mestdagh, Pieter Oncotarget Review Metastatic melanoma of the skin has a high mortality despite the recent introduction of targeted therapy and immunotherapy. Long non-coding RNAs (lncRNAs) are defined as transcripts of more than 200 nucleotides in length that lack protein-coding potential. There is growing evidence that lncRNAs play an important role in gene regulation, including oncogenesis. We present 13 lncRNA genes involved in the pathogenesis of cutaneous melanoma through a variety of pathways and molecular interactions. Some of these lncRNAs are possible biomarkers or therapeutic targets for malignant melanoma. Impact Journals LLC 2017-03-22 /pmc/articles/PMC5522162/ /pubmed/28415644 http://dx.doi.org/10.18632/oncotarget.16478 Text en Copyright: © 2017 Hulstaert et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Review
Hulstaert, Eva
Brochez, Lieve
Volders, Pieter-Jan
Vandesompele, Jo
Mestdagh, Pieter
Long non-coding RNAs in cutaneous melanoma: clinical perspectives
title Long non-coding RNAs in cutaneous melanoma: clinical perspectives
title_full Long non-coding RNAs in cutaneous melanoma: clinical perspectives
title_fullStr Long non-coding RNAs in cutaneous melanoma: clinical perspectives
title_full_unstemmed Long non-coding RNAs in cutaneous melanoma: clinical perspectives
title_short Long non-coding RNAs in cutaneous melanoma: clinical perspectives
title_sort long non-coding rnas in cutaneous melanoma: clinical perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522162/
https://www.ncbi.nlm.nih.gov/pubmed/28415644
http://dx.doi.org/10.18632/oncotarget.16478
work_keys_str_mv AT hulstaerteva longnoncodingrnasincutaneousmelanomaclinicalperspectives
AT brochezlieve longnoncodingrnasincutaneousmelanomaclinicalperspectives
AT volderspieterjan longnoncodingrnasincutaneousmelanomaclinicalperspectives
AT vandesompelejo longnoncodingrnasincutaneousmelanomaclinicalperspectives
AT mestdaghpieter longnoncodingrnasincutaneousmelanomaclinicalperspectives